Technology Offer

SpliSense

Summary of the technology

Modulation of the CFTR gene splicing for treatment of CF
Project ID : 26-2016-4370

Details of the Technology Offer

Company Profile

Splisense is developing targeted therapies for genetic diseases based on splicing modulation treating the underlying root cause of the disease.

SpliSense’s initial focus is on Cystic Fibrosis. SpliSense is developing a new class of therapies which treat the underlying genetic cause of the disease, leading to the production of a normal protein.

Project manager

Mel Larrosa
VP Business Development Healthcare

Project researchers

Batsheva Kerem
HUJI, Faculty of Science
The Alexander Silberman Institute for Life Sciences

Related Keywords

  • Socio-economic development models, economic aspects
  • Biological Sciences
  • Medicine, Human Health
  • Other (uncategorised)
  • Medical Health related
  • Investment Opportunities
  • Life Science & Biotechnology

About Yissum - Research Development Company of the Hebrew University

Yissum - Research Development Company of the Hebrew University

Yissum - Research Development Company of the Hebrew University

Technology Transfer Office from Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Related Technology Offers

Real Time Edge Detection of Objects in Pictures and Videos, without Artifacts

Real Time Edge Detection of Objects in Pictures and Videos, without Artifacts

Innovative Products and Technologies
  • +6 months
  • Hide post
Fast Image and Video Resolution Upscaling

Fast Image and Video Resolution Upscaling

Innovative Products and Technologies
  • Read more
  • Share
  • +6 months
  • Hide post

Controlled Release Formulations for Anionic Herbicides

Innovative Products and Technologies
  • Read more
  • Share
  • +6 months
  • Hide post

Super Active Leptin Antagonists for Treatment of Autoimmune Diseases and CKD-associated Cachexia

Innovative Products and Technologies
  • +6 months
  • Hide post

Oxidized Cellulose Used to Prevent Allergic Reaction in Asthma, Seasonal Allergies, and Atopic Dermatitis

Innovative Products and Technologies
  • +6 months
  • Hide post
Yissum - Research Development Company of the Hebrew University

Never miss an update from Yissum - Research Development Company of the Hebrew University

Create your free account to connect with Yissum - Research Development Company of the Hebrew University and thousands of other innovative organizations and professionals worldwide

Sign upLog in
Yissum - Research Development Company of the Hebrew University

Send a request for information
to Yissum - Research Development Company of the Hebrew University

By clicking "Send message" you are signing up and accepting our Terms of Service and Privacy policy

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support